Myocardial positron tomography with manganese-52m

Area of Science:

• Nuclear Medicine
• Cardiovascular Imaging
• Radiopharmaceutical Biodistribution

Background:

• Assessing myocardial perfusion is crucial for diagnosing and managing heart disease.
• Developing novel radiotracers with favorable biodistribution properties is essential for improving diagnostic accuracy.

Purpose of the Study:

• To evaluate the biodistribution of radiomanganese (54Mn) in preclinical models (mice, rats, dogs).
• To assess the potential of 52mMn for myocardial perfusion imaging using positron emission tomography (PET).

Main Methods:

• Studied biodistribution of 54Mn in mice, rats, and dogs.
• Administered 52mMn for PET imaging in dogs.
• Correlated radiomanganese distribution with microsphere data in infarcted canine hearts.

Main Results:

• 54Mn exhibited rapid blood clearance (half-time ~0.8 min) in all species.
• Achieved high myocardium-to-blood ratios (>40:1 at 15 min) in dogs.
• PET imaging with 52mMn demonstrated regional myocardial perfusion effectively.
• Showed strong correlation (r=0.89) between 54Mn and microsphere distribution in infarcted hearts.

Conclusions:

• Radiomanganese (54Mn) possesses excellent biodistribution characteristics for myocardial imaging.
• 52mMn is a viable positron-emitting isotope for assessing regional myocardial perfusion.
• The findings support the potential clinical utility of radiomanganese in cardiovascular diagnostics.